Alerts will be sent to your verified email
Verify Email
BALAXI
|
Balaxi Pharma.
|
Themis Medicare
|
Bajaj Healthcare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
41.22 % | 13.04 % | 18.48 % |
|
5yr average Equity Multiplier
|
1.49 | 1.72 | 2.14 |
|
5yr Average Asset Turnover Ratio
|
1.76 | 0.67 | 1.07 |
|
5yr Avg Net Profit Margin
|
15.32 % | 11.29 % | 8.14 % |
|
Price to Book
|
4.28 | 5.5 | 2.82 |
|
P/E
|
0.0 | 44.26 | 41.92 |
|
5yr Avg Cash Conversion Cycle
|
78.42 Days | 62.75 Days | 124.58 Days |
|
Inventory Days
|
40.39 Days | 82.4 Days | 53.75 Days |
|
Days Receivable
|
43.31 Days | 126.49 Days | 111.65 Days |
|
Days Payable
|
57.73 Days | 162.52 Days | 70.93 Days |
|
5yr Average Interest Coverage Ratio
|
304.38 | 5.22 | 7.43 |
|
5yr Avg ROCE
|
49.99 % | 16.01 % | 24.54 % |
|
5yr Avg Operating Profit Margin
|
18.92 % | 18.66 % | 16.5 % |
|
5 yr average Debt to Equity
|
0.03 | 0.4 | 0.75 |
|
5yr CAGR Net Profit
|
92.25 % | n/a | 21.41 % |
|
5yr Average Return on Assets
|
27.09 % | 8.13 % | 8.79 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
66.86 % | 67.15 % | 67.73 % |
|
Share Pledged by Promoters
|
0.0 | 2.43 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-6.0 % | -0.11 % | 0.47 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Balaxi Pharma.
|
Themis Medicare
|
Bajaj Healthcare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Drug Delivery Break-Up
|
Drug Delivery Break-Up
|
-
|
-
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|
